This Biotech Stock Surges 64%. The Big Pharma M&A Battle Is Heating Up.
RAPT TherapeuticsRAPT Therapeutics(US:RAPT) Barrons·2026-01-20 20:10

行业并购活动展望 - 投资者预期并购活动将在2026年激增 [1] - 驱动因素为制药公司需要补充产品管线 [1] - 驱动因素为制药公司希望利用低利率环境 [1]

RAPT Therapeutics-This Biotech Stock Surges 64%. The Big Pharma M&A Battle Is Heating Up. - Reportify